• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CCR5与阿尔茨海默病的关联

Entanglement of CCR5 and Alzheimer's Disease.

作者信息

Li Tianwen, Zhu Jianhong

机构信息

Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

State Key Laboratory of Medical Neurobiology, Shanghai, China.

出版信息

Front Aging Neurosci. 2019 Aug 7;11:209. doi: 10.3389/fnagi.2019.00209. eCollection 2019.

DOI:10.3389/fnagi.2019.00209
PMID:31447666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6692443/
Abstract

Although the mechanisms of Alzheimer's disease are diverse and unclear, the past 20 years have witnessed the unprecedented development of the AD inflammation theory. As a key inflammatory receptor family, the C-C chemokine receptor family is a remarkable participant in the cause of Alzheimer's disease; of this family, CCR5 is the most widely studied. CCR5 is an essential entrance when HIV infects immune cells and is also involved in other inflammatory and immune activities. New evidence on the inevitably intertwined link between Alzheimer's disease and CCR5 indicates that CCR5 accelerates the development of Alzheimer's disease, and few studies disputed it. The role of CCR5 in Alzheimer's disease remains elusive. However, as the research progresses, this intricate relationship will gradually be uncovered.

摘要

尽管阿尔茨海默病的发病机制多样且尚不明确,但在过去20年里,阿尔茨海默病炎症理论取得了前所未有的发展。作为关键的炎症受体家族,C-C趋化因子受体家族在阿尔茨海默病病因中是一个显著的参与者;在这个家族中,CCR5是研究最广泛的。CCR5是HIV感染免疫细胞时的一个重要入口,也参与其他炎症和免疫活动。关于阿尔茨海默病与CCR5之间不可避免地交织在一起的联系的新证据表明,CCR5加速了阿尔茨海默病的发展,很少有研究对此提出异议。CCR5在阿尔茨海默病中的作用仍然难以捉摸。然而,随着研究的进展,这种复杂的关系将逐渐被揭示出来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d036/6692443/e1cc73f0f000/fnagi-11-00209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d036/6692443/91867911231a/fnagi-11-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d036/6692443/e1cc73f0f000/fnagi-11-00209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d036/6692443/91867911231a/fnagi-11-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d036/6692443/e1cc73f0f000/fnagi-11-00209-g002.jpg

相似文献

1
Entanglement of CCR5 and Alzheimer's Disease.CCR5与阿尔茨海默病的关联
Front Aging Neurosci. 2019 Aug 7;11:209. doi: 10.3389/fnagi.2019.00209. eCollection 2019.
2
Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease.趋化因子受体5拮抗剂D-丙氨酸-肽T-酰胺可减轻阿尔茨海默病神经炎症大鼠模型海马内小胶质细胞和星形胶质细胞的激活。
Neuroscience. 2005;134(2):671-6. doi: 10.1016/j.neuroscience.2005.04.029.
3
The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.趋化因子受体CCR5-Δ32基因突变对阿尔茨海默病无保护作用。
Neurosci Lett. 2004 Aug 19;366(3):312-4. doi: 10.1016/j.neulet.2004.05.058.
4
Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).CCR2-64I 和 CCR5Δ32 多态性与晚发性阿尔茨海默病患者; 来自伊朗的研究(CCR2-64I 和 CCR5Δ32 多态性与阿尔茨海默病)。
Iran J Basic Med Sci. 2012 Jul;15(4):937-44.
5
Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications.针对阿尔茨海默病中的神经炎症:从机制到临床应用
Neural Regen Res. 2023 Apr;18(4):708-715. doi: 10.4103/1673-5374.353484.
6
Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.阿尔茨海默病中的神经炎症:星形胶质细胞产生的趋化因子和趋化因子受体
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8342-55. eCollection 2014.
7
Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.阿尔茨海默病中的神经炎症:分子信号传导与治疗的当前进展
Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20.
8
CCR5 receptor: biologic and genetic implications in age-related diseases.CCR5受体:在与年龄相关疾病中的生物学和遗传学意义
Ann N Y Acad Sci. 2007 Apr;1100:162-72. doi: 10.1196/annals.1395.014.
9
Insight into the roles of CCR5 in learning and memory in normal and disordered states.解析 CCR5 在正常和异常状态下学习和记忆中的作用。
Brain Behav Immun. 2021 Feb;92:1-9. doi: 10.1016/j.bbi.2020.11.037. Epub 2020 Dec 1.
10
CCR5 deficiency accelerates lipopolysaccharide-induced astrogliosis, amyloid-beta deposit and impaired memory function.CCR5缺陷会加速脂多糖诱导的星形胶质细胞增生、β-淀粉样蛋白沉积以及记忆功能受损。
Oncotarget. 2016 Mar 15;7(11):11984-99. doi: 10.18632/oncotarget.7453.

引用本文的文献

1
An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease.一项关于贝齐司替林治疗与轻度至中度可能的阿尔茨海默病患者生物年龄加速降低、临床指标改善及生物标志物变化相关的探索性分析。
Front Neurosci. 2025 May 2;19:1516746. doi: 10.3389/fnins.2025.1516746. eCollection 2025.
2
Deep learning and generative artificial intelligence in aging research and healthy longevity medicine.深度学习与生成式人工智能在衰老研究和健康长寿医学中的应用
Aging (Albany NY). 2025 Jan 16;17(1):251-275. doi: 10.18632/aging.206190.
3

本文引用的文献

1
CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury.CCR5 是中风和创伤性脑损伤后恢复的治疗靶点。
Cell. 2019 Feb 21;176(5):1143-1157.e13. doi: 10.1016/j.cell.2019.01.044.
2
Changes in Chemokines and Chemokine Receptors Expression in a Mouse Model of Alzheimer's Disease.阿尔茨海默病小鼠模型中趋化因子及其受体表达的变化。
Int J Biol Sci. 2019 Jan 1;15(2):453-463. doi: 10.7150/ijbs.26703. eCollection 2019.
3
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults.成人非酒精性脂肪性肝炎的现有和新兴药物治疗方法。
Amino Acid Compound 2 (AAC2) Treatment Counteracts Insulin-Induced Synaptic Gene Expression and Seizure-Related Mortality in a Mouse Model of Alzheimer's Disease.
氨基酸化合物 2(AAC2)治疗可逆转阿尔茨海默病小鼠模型中胰岛素诱导的突触基因表达和与癫痫发作相关的死亡率。
Int J Mol Sci. 2024 Oct 30;25(21):11689. doi: 10.3390/ijms252111689.
4
Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype.Tg2576 幼鼠实验性结肠炎加速类似阿尔茨海默病的临床表型的发生。
Alzheimers Res Ther. 2024 May 21;16(1):116. doi: 10.1186/s13195-024-01471-2.
5
Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.基于结构构象动力学和药物重定位方法,从 FDA 批准的数据库中计算预测阿尔茨海默病药物的疗效。
Sci Rep. 2023 Oct 21;13(1):18022. doi: 10.1038/s41598-023-45347-1.
6
Biomedical generative pre-trained based transformer language model for age-related disease target discovery.基于生物医学生成式预训练的转化器语言模型在与年龄相关疾病靶点发现中的应用。
Aging (Albany NY). 2023 Sep 22;15(18):9293-9309. doi: 10.18632/aging.205055.
7
Transcriptomics Meta-Analysis Reveals Phagosome and Innate Immune System Dysfunction as Potential Mechanisms in the Cortex of Alzheimer's Disease Mouse Strains.转录组学荟萃分析揭示了吞噬体和固有免疫系统功能障碍可能是阿尔茨海默病小鼠模型皮质中的机制。
J Mol Neurosci. 2023 Oct;73(9-10):773-786. doi: 10.1007/s12031-023-02152-9. Epub 2023 Sep 21.
8
CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia.CCR5 缺陷:神经元对氧化应激的抵抗力降低,血管性痴呆的风险增加。
Alzheimers Dement. 2024 Jan;20(1):124-135. doi: 10.1002/alz.13392. Epub 2023 Jul 25.
9
CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.CCR5 作为人类免疫缺陷病毒和猴免疫缺陷病毒的核心受体:一种典型的爱恨情仇关系。
Front Immunol. 2022 Jan 27;13:835994. doi: 10.3389/fimmu.2022.835994. eCollection 2022.
10
Therapeutic Mechanism and Key Alkaloids of in Alzheimer's Disease From the Perspective of Pathophysiological Processes.从病理生理过程角度看阿尔茨海默病的治疗机制及关键生物碱
Front Pharmacol. 2021 Dec 15;12:806984. doi: 10.3389/fphar.2021.806984. eCollection 2021.
Expert Opin Pharmacother. 2019 Jan;20(1):69-82. doi: 10.1080/14656566.2018.1543403. Epub 2018 Nov 9.
4
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.延长 CCR5 阻断预防移植物抗宿主病可改善降低强度无关供者造血细胞移植的结局:一项 II 期临床试验。
Biol Blood Marrow Transplant. 2019 Mar;25(3):515-521. doi: 10.1016/j.bbmt.2018.09.034. Epub 2018 Oct 10.
5
Inflammation: the link between comorbidities, genetics, and Alzheimer's disease.炎症:共病、遗传学与阿尔茨海默病之间的联系。
J Neuroinflammation. 2018 Sep 24;15(1):276. doi: 10.1186/s12974-018-1313-3.
6
Can inflammation be resolved in Alzheimer's disease?阿尔茨海默病中的炎症能够被消除吗?
Ther Adv Neurol Disord. 2018 Aug 9;11:1756286418791107. doi: 10.1177/1756286418791107. eCollection 2018.
7
CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.CCR5 再探:HIV 进入的机制如何影响艾滋病发病机制。
J Mol Biol. 2018 Aug 17;430(17):2557-2589. doi: 10.1016/j.jmb.2018.06.027. Epub 2018 Jun 19.
8
CXCR4 involvement in neurodegenerative diseases.CXCR4 在神经退行性疾病中的作用。
Transl Psychiatry. 2018 Apr 11;8(1):73. doi: 10.1038/s41398-017-0049-7.
9
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.炎症可能是血脂异常与阿尔茨海默病之间的联系。
Neuroscience. 2018 Apr 15;376:127-141. doi: 10.1016/j.neuroscience.2018.02.012. Epub 2018 Feb 14.
10
Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis.塞尼西维罗克用于治疗非酒精性脂肪性肝炎和肝纤维化。
Expert Opin Investig Drugs. 2018 Mar;27(3):301-311. doi: 10.1080/13543784.2018.1442436. Epub 2018 Feb 22.